Delivery Order SPE2DB25D7068-SPE2DB25FTYCF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,380.20 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial tuberculin skin test antigen. This competitively awarded, firm fixed-price delivery order was executed on August 29, 2025, with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- The Defense Logistics Agency awarded a $2,281.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculin skin test antigen used for tuberculosis screening. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a $2,141.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for Tubersol 5T Unit/0.1 ML Vial 5ML tuberculin skin test antigen. This firm fixed-price delivery order is scheduled for completion by June 17, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilized no set-aside designation, indicating competitive award through open bidding processes. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.04 on August 19, 2025, for the supply of Tubersol 5T Unit/0.1 mL vial 5mL tuberculin skin test antigen. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $1,155.00 to supply TUBERSOL 5T UNIT/0.1 ML VIAL tuberculosis skin test antigen. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This delivery order, awarded on August 27, 2025, to AmerisourceBergen Drug Corp, provides $2,797.86 in firm fixed price pharmaceutical supplies to the Defense Logistics Agency. Specifically, the contract calls for delivery of Tubersol 5T tuberculin skin test units in 0.1 milliliter vials with 5 milliliter capacity to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of August 28, 2025....
- The Defense Logistics Agency (DLA) awarded a $1,100 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Tubersol 5T Unit/0.1 mL vials. This competitive, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The company will perform this delivery order from its corporate office location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a firm fixed price of $2,141.90 and an ultimate completion date of May 13, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical and medical products to support military and government...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.60, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 19, 2024. The contract was awarded on November 18, 2024 and does not have a set-aside...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.40 order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYCFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,927.62 to AmerisourceBergen Drug Corp for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculin skin test antigen product. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations through DLA's medical supply chain. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical commodities to defense and veteran healthcare systems. The tuberculin skin test antigen procurement supports occupational health and medical screening requirements across Department of Defense facilities and personnel. The contract reflects DLA's ongoing strategy to maintain reliable pharmaceutical supply chains through established prime vendor relationships with qualified distributors capable of meeting federal medical procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |